BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 25870184)

  • 1. Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway.
    Bibli SI; Andreadou I; Chatzianastasiou A; Tzimas C; Sanoudou D; Kranias E; Brouckaert P; Coletta C; Szabo C; Kremastinos DT; Iliodromitis EK; Papapetropoulos A
    Cardiovasc Res; 2015 Jun; 106(3):432-42. PubMed ID: 25870184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt/eNOS signaling and PLN S-sulfhydration are involved in H₂S-dependent cardiac effects in frog and rat.
    Mazza R; Pasqua T; Cerra MC; Angelone T; Gattuso A
    Am J Physiol Regul Integr Comp Physiol; 2013 Aug; 305(4):R443-51. PubMed ID: 23785074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
    Efentakis P; Varela A; Chavdoula E; Sigala F; Sanoudou D; Tenta R; Gioti K; Kostomitsopoulos N; Papapetropoulos A; Tasouli A; Farmakis D; Davos CH; Klinakis A; Suter T; Cokkinos DV; Iliodromitis EK; Wenzel P; Andreadou I
    Cardiovasc Res; 2020 Mar; 116(3):576-591. PubMed ID: 31228183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling.
    Inserte J; Hernando V; Vilardosa Ú; Abad E; Poncelas-Nozal M; Garcia-Dorado D
    J Am Heart Assoc; 2013 Jan; 2(1):e005975. PubMed ID: 23525447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of cGMP/PKG pathway and colonic motility by hydrogen sulfide.
    Nalli AD; Bhattacharya S; Wang H; Kendig DM; Grider JR; Murthy KS
    Am J Physiol Gastrointest Liver Physiol; 2017 Oct; 313(4):G330-G341. PubMed ID: 28705807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen sulfide regulates Na+/H+ exchanger activity via stimulation of phosphoinositide 3-kinase/Akt and protein kinase G pathways.
    Hu LF; Li Y; Neo KL; Yong QC; Lee SW; Tan BK; Bian JS
    J Pharmacol Exp Ther; 2011 Nov; 339(2):726-35. PubMed ID: 21865440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase.
    Frankenreiter S; Groneberg D; Kuret A; Krieg T; Ruth P; Friebe A; Lukowski R
    Cardiovasc Res; 2018 May; 114(6):822-829. PubMed ID: 29438488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
    Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
    Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
    Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes.
    Pan TT; Feng ZN; Lee SW; Moore PK; Bian JS
    J Mol Cell Cardiol; 2006 Jan; 40(1):119-30. PubMed ID: 16325198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation.
    Gorbe A; Giricz Z; Szunyog A; Csont T; Burley DS; Baxter GF; Ferdinandy P
    Basic Res Cardiol; 2010 Sep; 105(5):643-50. PubMed ID: 20349314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
    Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
    Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
    Salloum FN; Das A; Samidurai A; Hoke NN; Chau VQ; Ockaili RA; Stasch JP; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1347-54. PubMed ID: 22268103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
    Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
    Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotective PKG-independent NO signaling at reperfusion.
    Cohen MV; Yang XM; Liu Y; Solenkova NV; Downey JM
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2028-36. PubMed ID: 20852051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.
    Nikolaou PE; Boengler K; Efentakis P; Vouvogiannopoulou K; Zoga A; Gaboriaud-Kolar N; Myrianthopoulos V; Alexakos P; Kostomitsopoulos N; Rerras I; Tsantili-Kakoulidou A; Skaltsounis AL; Papapetropoulos A; Iliodromitis EK; Schulz R; Andreadou I
    Cardiovasc Res; 2019 Jun; 115(7):1228-1243. PubMed ID: 30843027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion.
    Salie R; Alsalhin AKH; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of RhoA-dependent pathway and contraction by endogenous hydrogen sulfide in rabbit gastric smooth muscle cells.
    Nalli AD; Rajagopal S; Mahavadi S; Grider JR; Murthy KS
    Am J Physiol Cell Physiol; 2015 Mar; 308(6):C485-95. PubMed ID: 25567809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous hydrogen sulphide mediates the cardioprotection induced by ischemic postconditioning.
    Yong QC; Lee SW; Foo CS; Neo KL; Chen X; Bian JS
    Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1330-H1340. PubMed ID: 18660450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.